Keyphrases
Assisted Reproductive Technology
100%
Cancer History
100%
Cancer Diagnosis
50%
Live Birth Rate
43%
Autologous Oocytes
31%
Donor Oocyte
31%
Breast Cancer
25%
Live Birth
25%
Prior Cancer
25%
Female Cancer
18%
Confidence Interval
12%
Adjusted Odds Ratio
12%
Women with Breast Cancer
12%
Survivors
6%
Medical Surveillance
6%
Illness
6%
Childhood Cancer
6%
Cancer Treatment
6%
Early childhood
6%
Residency
6%
Chemotherapy-induced
6%
Cervical Cancer
6%
National Cancer Institute
6%
Reporting System
6%
All Cancer
6%
Negative Effects
6%
Female Genital
6%
All-female
6%
Ovarian Follicle
6%
With Woman
6%
Logistic Regression
6%
Spontaneous Preterm Birth (sPTB)
6%
National Institutes of Health
6%
Individual State
6%
Fertility Preservation
6%
Birth Timing
6%
Endocrine Cancer
6%
Age Distribution
6%
Conflict of Interest
6%
Periconceptional Period
6%
Social Security number
6%
Preconceptional
6%
Population-based Cohort Study
6%
State Cancer Registry
6%
Spontaneous Conception
6%
Setting Method
6%
Outcome Reporting
6%
Competing Interests
6%
Registry-based
6%
Infertility Diagnosis
6%
Premenopausal Patients
6%
Vital Records
6%
Genital Cancer
6%
Clinic Outcomes
6%
Embryo Banking
6%
Assisted Reproductive Technology Outcomes
6%
Live Birth Outcomes
6%
Women Age
6%
Destructive Behavior
6%
System Database
6%
Assisted Reproductive Technology Cycles
6%
Medicine and Dentistry
Malignant Neoplasm
100%
Assisted Reproductive Technology
100%
Oocyte
37%
Cancer Diagnosis
29%
Birth Rate
25%
Breast Cancer
22%
Cancer
11%
Gene Linkage
7%
Odds Ratio
7%
Cancer Therapy
3%
Cohort Analysis
3%
Female Genital Tract Cancer
3%
Childhood Cancer
3%
Prevalence
3%
Population Research
3%
Cervical Cancer
3%
Cancer Registry
3%
Birth Outcomes
3%
Logistic Regression Analysis
3%
Conception
3%
Follitropin
3%
Ovarian Follicle
3%
Fertility Preservation
3%
Age Distribution
3%
Endocrine Cancer
3%
Periodic Medical Examination
3%
Diseases
3%